Published in Neurosci Lett on February 17, 2012
Cell transplantation for spinal cord injury: a systematic review. Biomed Res Int (2013) 1.11
Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration. Stem Cells Int (2015) 0.84
Low piconewton towing of CNS axons against diffusing and surface-bound repellents requires the inhibition of motor protein-associated pathways. Sci Rep (2014) 0.82
Bridging the lesion-engineering a permissive substrate for nerve regeneration. Regen Biomater (2015) 0.79
A Systematic Review of Experimental Strategies Aimed at Improving Motor Function after Acute and Chronic Spinal Cord Injury. J Neurotrauma (2016) 0.78
Carriers in cell-based therapies for neurological disorders. Int J Mol Sci (2014) 0.77
Spatial and temporal dynamics of neurite regrowth. Curr Opin Neurobiol (2013) 0.76
Analyzing the role of extracellular matrix during nervous system development to advance new regenerative strategies. Neural Regen Res (2017) 0.75
The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil (2006) 9.55
Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature (2002) 8.22
Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry (1982) 6.87
Basement membrane complexes with biological activity. Biochemistry (1986) 6.79
Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem (1968) 5.66
Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci (2005) 5.66
Embryonic stem cells express neuronal properties in vitro. Dev Biol (1995) 5.03
Therapeutic interventions after spinal cord injury. Nat Rev Neurosci (2006) 4.51
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A (2002) 4.03
Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science (1981) 3.94
Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med (1997) 3.55
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35
Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature (1990) 3.22
Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci (2006) 3.21
Spinal axon regeneration induced by elevation of cyclic AMP. Neuron (2002) 3.09
The cellular inflammatory response in human spinal cords after injury. Brain (2006) 3.01
The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev (2007) 2.42
Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci (2005) 2.30
Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature (1990) 2.28
Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci (2003) 2.23
Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci (2006) 2.13
The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci (2003) 2.11
Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci (1997) 2.07
Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci (2002) 1.98
Acute inflammatory response in spinal cord following impact injury. Exp Neurol (1998) 1.87
A review of the neuropathology of human spinal cord injury with emphasis on special features. J Spinal Cord Med (1999) 1.86
The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury. Exp Neurol (2007) 1.82
Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol (1995) 1.70
Multiple-channel scaffolds to promote spinal cord axon regeneration. Biomaterials (2005) 1.68
Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp Neurol (1997) 1.58
Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci U S A (2009) 1.48
Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci (2010) 1.46
Combining peripheral nerve grafts and chondroitinase promotes functional axonal regeneration in the chronically injured spinal cord. J Neurosci (2009) 1.45
In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials (2005) 1.45
Growth factors and combinatorial therapies for CNS regeneration. Exp Neurol (2007) 1.44
NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. Eur J Neurosci (1999) 1.38
Schwann cell transplantation for repair of the adult spinal cord. J Neurotrauma (2006) 1.37
Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. Eur J Neurosci (2003) 1.34
Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev (2007) 1.28
Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery. PLoS One (2009) 1.27
Current and future therapeutic strategies for functional repair of spinal cord injury. Pharmacol Ther (2011) 1.25
Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull (2010) 1.25
Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury. Neurosurgery (2007) 1.24
Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination. J Comp Neurol (2003) 1.22
Templated agarose scaffolds support linear axonal regeneration. Tissue Eng (2006) 1.21
Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A (2009) 1.21
Spinal cord injury facts and figures at a glance. J Spinal Cord Med (2010) 1.18
Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PLoS One (2009) 1.15
Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol (1994) 1.15
Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. Eur J Neurosci (1998) 1.14
Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp Neurol (2007) 1.13
GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury. Exp Neurol (2011) 1.11
Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter (2010) 1.09
Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain. J Tissue Eng Regen Med (2009) 1.08
Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury. Spinal Cord (2006) 1.03
Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng (2009) 1.01
Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. Eur J Neurosci (2005) 0.98
Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull (2002) 0.97
Engineering angiogenesis following spinal cord injury: a coculture of neural progenitor and endothelial cells in a degradable polymer implant leads to an increase in vessel density and formation of the blood-spinal cord barrier. Eur J Neurosci (2009) 0.97
Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats. Tissue Eng Part A (2009) 0.94
Comparison of polymer scaffolds in rat spinal cord: a step toward quantitative assessment of combinatorial approaches to spinal cord repair. Biomaterials (2011) 0.93
Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection. Tissue Eng Part A (2008) 0.91
Glial cell line-derived neurotrophic factor increases calcitonin gene-related peptide immunoreactivity in sensory and motoneurons in vivo. Eur J Neurosci (2003) 0.90
Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor to bone marrow stromal cells promotes axonal regeneration after transplantation in completely transected adult rat spinal cord. Eur Spine J (2007) 0.90
Neuronal populations capable of regeneration following a combined treatment in rats with spinal cord transection. J Neurotrauma (2007) 0.89
Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stem cells. J Neurosci Methods (2010) 0.89
Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels. Tissue Eng Part A (2011) 0.89
Enrichment of Schwann cell cultures from neonatal rat sciatic nerve by differential adhesion. Brain Res (1981) 0.88
A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI. Exp Neurol (2010) 0.88
Suspension matrices for improved Schwann-cell survival after implantation into the injured rat spinal cord. J Neurotrauma (2010) 0.88
Bone marrow stromal cells-loaded chitosan conduits promote repair of complete transection injury in rat spinal cord. J Mater Sci Mater Med (2011) 0.85
Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-L-lysine to promote axon regrowth after spinal cord injury. J Biomed Mater Res B Appl Biomater (2010) 0.84
Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats. PLoS One (2011) 0.84
Combined NgR vaccination and neural stem cell transplantation promote functional recovery after spinal cord injury in adult rats. Neuropathol Appl Neurobiol (2011) 0.83
Combination of olfactory ensheathing cells with local versus systemic cAMP treatment after a cervical rubrospinal tract injury. J Neurosci Res (2010) 0.83
Neural regrowth induced by PLGA nerve conduits and neurotrophin-3 in rats with complete spinal cord transection. J Biomed Mater Res B Appl Biomater (2011) 0.81
Combination of multifaceted strategies to maximize the therapeutic benefits of neural stem cell transplantation for spinal cord repair. Cell Transplant (2011) 0.79
The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages. Biomaterials (2008) 1.58
Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol (2003) 1.49
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release (2004) 1.32
Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev (2007) 1.28
Neurite outgrowth on nanofiber scaffolds with different orders, structures, and surface properties. ACS Nano (2009) 1.28
The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffolds. Stem Cells (2007) 1.23
The early effects of sustained platelet-derived growth factor administration on the functional and structural properties of repaired intrasynovial flexor tendons: an in vivo biomechanic study at 3 weeks in canines. J Hand Surg Am (2007) 1.22
Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release (2006) 1.19
Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices. J Biomed Mater Res A (2007) 1.15
Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter (2010) 1.09
Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration. Acta Biomater (2008) 1.08
The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. Stem Cell Res (2008) 1.06
Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury. J Biomed Mater Res A (2010) 1.06
Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant (2009) 1.04
Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J Control Release (2006) 1.04
Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng (2009) 1.01
BMP12 induces tenogenic differentiation of adipose-derived stromal cells. PLoS One (2013) 1.00
Anisotropic mechanical properties of magnetically aligned fibrin gels measured by magnetic resonance elastography. J Biomech (2009) 1.00
Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev (2007) 0.99
Differential gene expression in motor and sensory Schwann cells in the rat femoral nerve. J Neurosci Res (2011) 0.95
Development of rationally designed affinity-based drug delivery systems. Acta Biomater (2005) 0.94
The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles. J Gene Med (2008) 0.93
Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system. J Biomed Mater Res A (2009) 0.93
Fibrin matrices with affinity-based delivery systems and neurotrophic factors promote functional nerve regeneration. Biotechnol Bioeng (2010) 0.93
Conductive Core-Sheath Nanofibers and Their Potential Application in Neural Tissue Engineering. Adv Funct Mater (2009) 0.92
The early inflammatory response after flexor tendon healing: a gene expression and histological analysis. J Orthop Res (2014) 0.92
Schwann cells seeded in acellular nerve grafts improve functional recovery. Muscle Nerve (2013) 0.89
A systematic evaluation of Schwann cell injection into acellular cold-preserved nerve grafts. J Neurosci Methods (2011) 0.88
Transgenic enrichment of mouse embryonic stem cell-derived progenitor motor neurons. Stem Cell Res (2011) 0.86
Generation of v2a interneurons from mouse embryonic stem cells. Stem Cells Dev (2014) 0.85
Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems. J Biomed Mater Res A (2008) 0.85
Engineering peripheral nerve repair. Curr Opin Biotechnol (2013) 0.84
Heparin-binding-affinity-based delivery systems releasing nerve growth factor enhance sciatic nerve regeneration. J Biomater Sci Polym Ed (2010) 0.82
A microdevice platform for visualizing mitochondrial transport in aligned dopaminergic axons. J Neurosci Methods (2012) 0.81
Controlled delivery of glial cell line-derived neurotrophic factor enhances motor nerve regeneration. J Hand Surg Am (2010) 0.81
Synthesis and characterization of four-arm poly(ethylene glycol)-based gene delivery vehicles coupled to integrin and DNA-binding peptides. Mol Pharm (2007) 0.80
A new method for generating high purity motoneurons from mouse embryonic stem cells. Biotechnol Bioeng (2014) 0.80
Development of novel poly(ethylene glycol)-based vehicles for gene delivery. Biotechnol Bioeng (2007) 0.79
Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides. Acta Biomater (2008) 0.77
Viral transduction of primary Schwann cells using a Cre-lox system to regulate GDNF expression. Biotechnol Bioeng (2014) 0.77
Kinetic analysis of neurotrophin-3-mediated differentiation of embryonic stem cells into neurons. Tissue Eng Part A (2009) 0.76
Analysis of cell binding and internalization of multivalent PEG-based gene delivery vehicles. IEEE Trans Nanobioscience (2011) 0.76
Abstract 91: Engineering Primary Schwann Cells using Lentiviruses to Control GDNF Expression. Plast Reconstr Surg (2014) 0.75
Effects of borate-based bioactive glass on neuron viability and neurite extension. J Biomed Mater Res A (2013) 0.75
Getting your research out there: open access & more. Ann Biomed Eng (2012) 0.75